![Jodie Morrison](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jodie Morrison
Chief Executive Officer at
Q32 Bio, Inc.
Net worth: 1 M $ as of 2026-05-30
Profile
Jodie P.
Morrison is the founder of Morrison Advisory Consulting.
Current roles include Chief Executive Officer & Director at Q32 Bio, Inc. since 2024; President, Chief Executive Officer & Secretary at Q32 Bio Operations, Inc.; Director at Rectify Pharmaceuticals LLC; President, Secretary & Director at Q32 Bio Securities Corp.; Advisor at Atlas Venture Advisors, Inc. since 2021; and Advisor at Atlas Venture Life Science Advisors LLC since 2021.
Former positions include Chief Executive Officer & Director at Keryx Biopharmaceuticals, Inc. in 2018; President, Chief Executive Officer & Director at Tokai Pharmaceuticals, Inc. from 2013 to 2017; Chief Executive Officer & Director at Cadent Therapeutics, Inc. from 2019 to 2021; President & Chief Executive Officer at eGenesis, Inc. in 2017; Chairman at Ribon Therapeutics, Inc.; Director-Clinical Operations at Dyax Corp.
from 2012 to 2013; Independent Director at Rein Therapeutics, Inc. from 2017 to 2023; Independent Director at Akebia Therapeutics, Inc. from 2018 to 2020; Member Board Of Directors and Director at Eledon Pharmaceuticals, Inc. from 2013 to 2018; Independent Director at Verve Therapeutics, Inc. from 2024 to 2025; Principal at Diacrin, Inc. (Delaware); Principal at Curis, Inc.; and Chief Operating Officer at Syntimmune, Inc. in 2018.
Education includes undergraduate studies at Mount Holyoke College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.72% | 2026-04-14 | 122,104 ( 0.72% ) | 1 M $ | 2026-05-30 |
Jodie Morrison active positions
| Companies | Position | Start |
|---|---|---|
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | 2021-06-30 |
Rectify Pharmaceuticals LLC
 Rectify Pharmaceuticals LLC BiotechnologyHealth Technology Operates as a biotechnology company that develops positive functional modulators | Director/Board Member | - |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Chief Executive Officer | - |
Atlas Venture Life Science Advisors LLC
 Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for seed and early stage capital requirements. | Consultant / Advisor | - |
Former positions of Jodie Morrison
| Companies | Position | End |
|---|---|---|
| VERE THER | Director/Board Member | 2025-07-24 |
| REIN THERAPEUTICS INC. | Director/Board Member | 2023-10-30 |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders | Chief Executive Officer | 2021-02-28 |
| AKEBIA THERAPEUTICS, INC. | Director/Board Member | 2020-04-02 |
| KERYX BIOPHARMACEUTICALS | Chief Executive Officer | 2018-12-11 |
Training of Jodie Morrison
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
51
1st degree connections
19
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 19 |
|---|---|
Diacrin, Inc. (Delaware)
 Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Develops human cell transplant therapeutic products | Health Technology |
Dyax Corp.
 Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Curis, Inc.
 Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Rein Therapeutics, Inc.
 Rein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops stapled peptide drugs | Health Technology |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Engages in developing novel antibody therapies and severe toxicities in bio pharma industry | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Mount Holyoke College
 Mount Holyoke College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tokai Pharmaceuticals, Inc.
 Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel proprietary therapies for the treatment of prostate cancer and other hormonally driven diseases | Health Technology |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders | Health Technology |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for seed and early stage capital requirements. | Finance |
Ribon Therapeutics, Inc.
 Ribon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops cacner therapies | Health Technology |
eGenesis, Inc.
 eGenesis, Inc. Medical/Nursing ServicesHealth Services Operates as a biotechnology company that provides organs and cells transplantation services | Health Services |
Eledon Pharmaceuticals, Inc.
 Eledon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Verve Therapeutics, Inc.
 Verve Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat patients with cardiovascular disease | Health Technology |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Health Technology |
Rectify Pharmaceuticals LLC
Rectify Pharmaceuticals LLC BiotechnologyHealth Technology Operates as a biotechnology company that develops positive functional modulators | Health Technology |
Morrison Advisory Consulting |
- Stock Market
- Insiders
- Jodie Morrison
